SCHEMBL1089103

SCHEMBL1089103

CCN1CCCC1CNc1nc(N2CC3CCC(CC3)C2)c2ccccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.48
LMNA P02545 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
IRAK4 Q9NWZ3 2/20 0.43
MRGPRX1 Q96LB2 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
RAB9A P51151 1/20 0.43
VNN1 O95497 1/20 0.42
KMT2A Q03164 3/20 0.40
PIM1 P11309 2/20 0.40
PIM2 Q9P1W9 1/20 0.40
TLR7 Q9NYK1 1/20 0.40
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1088557 0.93 MRGPRX1 (0.51) ACHELMNAALDH1A1HPGDKDM4E
SCHEMBL1089781 0.92 MRGPRX1 (0.50) ACHELMNAALDH1A1HPGDKDM4E
SCHEMBL1089507 0.92 MRGPRX1 (0.50) ACHELMNAALDH1A1HPGDKDM4E
SCHEMBL1088730 0.92 MRGPRX1 (0.50) ACHELMNAALDH1A1HPGDKDM4E
SCHEMBL1089099 0.87 KAT2B (0.49) LMNAALDH1A1HPGDKDM4EHSD17B10
SCHEMBL1090755 0.86 ACHE (0.44) ACHELMNAALDH1A1HPGDKDM4E
SCHEMBL1090499 0.79 MRGPRX1 (0.53) LMNAALDH1A1HPGDKDM4EHSD17B10
SCHEMBL1089544 0.79 HRH2 (0.56) MRGPRX1RAB9A
SCHEMBL1089408 0.78 MRGPRX1 (0.52) LMNAALDH1A1HPGDKDM4EHSD17B10
SCHEMBL1089684 0.75 RAD52 (0.56) ACHELMNAALDH1A1KDM4EMRGPRX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ACHE 4384/4885LMNA 3658/4885ALDH1A1 916/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 ACHE 4384/4885LMNA 3658/4885ALDH1A1 916/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ACHE 4384/4885LMNA 3658/4885ALDH1A1 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.